Relationships between age and epi-genotype of the FMR1 exon 1/intron 1 boundary are consistent with non-random X-chromosome inactivation in FM individuals, with the selection for the unmethylated state being most significant between birth and puberty.

Methylation of the fragile X-related epigenetic element 2 (FREE2) located on the exon 1/intron 1 boundary of the FMR1 gene is related to FMRP expression and cognitive impairment in full mutation (FM; CGG>200) individuals. We examined the relationship between age, the size of the FMR1 CGG expansion and the methylation output ratio (MOR) at 12 CpG sites proximal to the exon 1/intron 1 boundary using FREE2 MALDI-TOF MS. The patient cohort included 119 males and 368 females, i.e. 121 healthy controls (CGG<40), 176 premutation (CGG 55-170) and 190 FM (CGG 213-2000). For all CpG units examined, FM males showed a significantly elevated MOR compared with that in hypermethylated FM females. In FM males the MOR for most CpG units significantly positively correlated with both age and CGG size (P< 0.05). In FM females the skewing towards the unmethylated state was significant for half of the units between birth and puberty (P < 0.05). The methylation status of intron 1 CpG10-12 that was most significantly related to cognitive impairment in our earlier study, did not change significantly with age in FM females. These results challenge the concept of fragile X syndrome (FXS)-related methylation being static over time, and suggest that due to the preference for the unmethylated state in FM females, X-inactivation at this locus is not random. The findings also highlight that the prognostic value of FXS methylation testing is not uniform between all CpG sites, and thus may need to be evaluated on a site-by-site basis.

[1]  W. Liu,et al.  Drosophila FMRP participates in the DNA damage response by regulating G2/M cell cycle checkpoint and apoptosis. , 2012, Human molecular genetics.

[2]  D. Loesch,et al.  Fragile X–related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study , 2012, Genetics in Medicine.

[3]  K. Kwon,et al.  Positive feedback regulation of Akt‐FMRP pathway protects neurons from cell death , 2012, Journal of neurochemistry.

[4]  D. Loesch,et al.  Fragile X mental retardation 1 (FMR1) intron 1 methylation in blood predicts verbal cognitive impairment in female carriers of expanded FMR1 alleles: evidence from a pilot study. , 2012, Clinical chemistry.

[5]  D. Loesch,et al.  FMR1 intron 1 methylation predicts FMRP expression in blood of female carriers of expanded FMR1 alleles. , 2011, The Journal of molecular diagnostics : JMD.

[6]  S. Fatemi,et al.  The role of fragile X mental retardation protein in major mental disorders , 2011, Neuropharmacology.

[7]  Robert W. Williams,et al.  Female-biased expression of long non-coding RNAs in domains that escape X-inactivation in mouse , 2010, BMC Genomics.

[8]  D. Loesch,et al.  Methylation of novel markers of fragile X alleles is inversely correlated with FMRP expression and FMR1 activation ratio. , 2010, Human molecular genetics.

[9]  D. Loesch,et al.  Linking the FMR1 alleles with small CGG expansions with neurodevelopmental disorders: Preliminary data suggest an involvement of epigenetic mechanisms , 2009, American journal of medical genetics. Part A.

[10]  Randi J. Hagerman,et al.  Advances in the Treatment of Fragile X Syndrome , 2009, Pediatrics.

[11]  M. Epstein,et al.  Fragile X‐associated primary ovarian insufficiency: evidence for additional genetic contributions to severity , 2008, Genetic epidemiology.

[12]  M. Khaniani,et al.  An improved Diagnostic PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1) , 2008, Molecular Cytogenetics.

[13]  C. Wahlestedt,et al.  A Novel RNA Transcript with Antiapoptotic Function Is Silenced in Fragile X Syndrome , 2008, PloS one.

[14]  S. Tapscott,et al.  An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. , 2007, Human molecular genetics.

[15]  M. Tejada,et al.  Analysis of FMR1 gene expression in female premutation carriers using robust segmented linear regression models. , 2007, RNA.

[16]  Lexin Li,et al.  Elevated FMR1 mRNA in premutation carriers is due to increased transcription. , 2007, RNA.

[17]  D. Loesch,et al.  Autism Spectrum Phenotype in Males and Females with Fragile X Full Mutation and Premutation , 2007, Journal of autism and developmental disorders.

[18]  L. Beckett,et al.  Size bias of fragile X premutation alleles in late-onset movement disorders , 2006, Journal of Medical Genetics.

[19]  D. Loesch,et al.  Autism Spectrum Disorders and Attention-Deficit/Hyperactivity Disorder in Boys with the Fragile X Premutation , 2006, Journal of developmental and behavioral pediatrics : JDBP.

[20]  J. Brunberg,et al.  Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. , 2004, JAMA.

[21]  M. D. Del Bigio,et al.  Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. , 2002, Brain : a journal of neurology.

[22]  M. Watson,et al.  Technical Standards and Guidelines for Fragile X: The First of a Series of Disease-Specific Supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics , 2001, Genetics in medicine : official journal of the American College of Medical Genetics.

[23]  B. Bardoni,et al.  Increase of FMRP expression, raised levels ofFMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations? , 2000, Journal of medical genetics.

[24]  W. Greenough,et al.  Dendritic spine structural anomalies in fragile-X mental retardation syndrome. , 2000, Cerebral cortex.

[25]  P. Hagerman,et al.  Transcription of the FMR1 gene in individuals with fragile X syndrome. , 2000, American journal of medical genetics.

[26]  I. Weiler,et al.  Synaptic synthesis of the Fragile X protein: possible involvement in synapse maturation and elimination. , 1999, American journal of medical genetics.

[27]  B. D. de Vries,et al.  Mental status of females with an FMR1 gene full mutation. , 1996, American journal of human genetics.

[28]  H. Willard,et al.  X inactivation of the FMR1 fragile X mental retardation gene. , 1995, Journal of medical genetics.

[29]  C. Mathew,et al.  A multicenter study on genotype-phenotype correlations in the fragile X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. , 1994, American journal of human genetics.

[30]  K. A. Lang,et al.  Molecular predictors of cognitive involvement in female carriers of fragile X syndrome. , 1994, JAMA.

[31]  G. Suthers Fragile X Syndrome—Diagnosis, Treatment, and Research , 1992 .

[32]  J. Mandel,et al.  Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation. , 1991, Journal of medical genetics.

[33]  Ben A. Oostra,et al.  Absence of expression of the FMR-1 gene in fragile X syndrome , 1991, Cell.

[34]  J. Sutcliffe,et al.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome , 1991, Cell.

[35]  C. Laird Proposed mechanism of inheritance and expression of the human fragile-X syndrome of mental retardation. , 1987, Genetics.

[36]  P. Hagerman,et al.  A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. , 2008, The Journal of molecular diagnostics : JMD.

[37]  D. Munoz Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. , 2002, Neurology.

[38]  Silverman,et al.  Fragile X Syndrome Diagnosis Treatment And Research , 2016 .